Skip to main content
SpringerLink
Log in

Zur Therapie des Zervixkarzinoms

Bericht vom 1. Gynäkologie-Seminar Gyn Update 2007

Therapy of cervix carcinomas

Report of the 1st Gynaecological Seminar Gyn Update 2007

  • Gynäkologie aktuell
  • Published:
Der Gynäkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Davey E, Barratt A, Irwig L et al. (2006) Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 367 (9505): 122–132

    Article  PubMed  Google Scholar 

  2. Cuzick J, Clavel C, Petry KU et al. (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119 (5): 1095–1101

    Article  PubMed  CAS  Google Scholar 

  3. Ronco G, Segnan N, Giorgi-Rossi P et al. ; New Technologies for Cervical Cancer Working Group (2006) Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 98 (11): 765–774

    Article  PubMed  Google Scholar 

  4. Villa LL, Costa RL, Petta CA et al. (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6 (5): 27127–8

    Article  Google Scholar 

  5. Villa LL, Ault KA, Giuliano AR et al. (2006) Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and18. Vaccine 24 (27–28): 5571–5583

    Google Scholar 

  6. Harper DM, Franco EL, Wheeler CM et al. (2006) Sustained efficacy up to 4. 5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 367 (9518): 1247–1255

    Google Scholar 

  7. Bipat S, Glas AS, van der Velden J et al. (2003) Computed tomography and magnetic resonance imaging in stagi ng of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91 (1): 59–66

    Article  PubMed  Google Scholar 

  8. Schlaerth JB, Spirtos NM, Schlaerth AC (2003) Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer. Am J Obstet Gynecol 188: 29–34

    Article  PubMed  Google Scholar 

  9. Boss EA, van Golde RJ, Beerendonk CC, Massuger LF (2005) Pregnancy after radical trachelectomy: a real option? Gynecol Oncol 99 (3 Suppl 1): S152-S156

    Article  PubMed  CAS  Google Scholar 

  10. Hertel H, Kohler C, Grund D, Hillemanns P, Possover M, Michels W, Schneider A; German Association of Gynecologic Oncologists (AGO): Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. Gynecol Oncol 103 (2): 506–511

    Article  Google Scholar 

  11. Marnitz S, Kohler C, Bongardt S et al. ;German Association of Gynecologic Oncologists (AGO) (2006) Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 103 (1): 35–44

    Article  PubMed  Google Scholar 

  12. Lee YS, Rhim CC, Lee HN et al. (2007) HPV status in sentinel nodes might be a prognostic factor in cervical cancer. Gynecol Oncol (Epub ahead of print)

  13. Popa I, Plante M, Renaud MC et al. (2006) Negative sentinel lymph node accurately predicts negative status of pelvic lymph nodes in uterine cervix carcinoma. Gynecol Oncol 103 (2): 649–653

    Article  PubMed  Google Scholar 

  14. Marnitz S, Kohler C, Roth C et al. (2005) Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol 99 (3): 536–544

    Article  PubMed  Google Scholar 

  15. Denschlag D, Gabriel B, Mueller-Lantzsch C et al. (2005) Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer. Gynecol Oncol 96 (3): 658–664

    Article  PubMed  CAS  Google Scholar 

  16. Kyrgiou M, Koliopoulos G, Martin-Hirsch P et al. (2006) Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367 (9509): 489–498

    Article  PubMed  CAS  Google Scholar 

  17. Moore DH, Blessing JA, McQuellon RP et al. (2004) Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 22 (15): 3113–3319

    Article  PubMed  CAS  Google Scholar 

  18. Long HJ 3rd, Bundy BN, Grendys EC Jr et al. (2005) Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 23 (21): 4626–4633

    Article  PubMed  CAS  Google Scholar 

  19. Garland SM, Hernandez-Avila M, Wheeler CM et al. (2007) Quadrivalent vaccine against human papillomavirus to prevent anogenital disease. N Engl J Med 356: 1928–1943

    Article  PubMed  CAS  Google Scholar 

  20. The FUTURE II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356: 1915–1927

    Article  Google Scholar 

  21. Viscidi R et al. (2005) Human Papillomavirus Capsid Antibody Response to Natural Infection and Risk of Subsequent HPV Infection in HIV-Positive and HIV-Negative Women. Cancer Epidemiol Biomarkers Prev 14: 283–288

    PubMed  CAS  Google Scholar 

  22. Leblanc E et al. (2005) Pretherapeutic laparoscopic staging of locally advanced cervical carcinomas: technique and results. Gynecol Oncol 99: 536–544

    Article  Google Scholar 

  23. Dursun P et al. (2007) Radical vagina trachelectomy (Dargent’s operation): a critical review of the literature. EJSO 4, Epub ahead of print

  24. Angioli R et al. (2005) Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. Gynecol Oncol 96: 504–509

    Article  PubMed  Google Scholar 

  25. Altenhofen L (2005) Hochrechnung zur Akzeptanz von Gesundheitsuntersuchungen und Krebsfrüherkennungsuntersuchungen bei gesetzlich Versicherten. Zentralinstitut für die kassenärztliche Versorgung in der Bundesrepublik Deutschland. Berlin..

  26. FIGO (2003) 25th FIGO report. Int J Gynecol Obstet 83 (suppl 1): 1–230

    Google Scholar 

Download references

Interessenkonflikt

Keine Angaben

Author information

Authors and Affiliations

  1. Windheimer Weg 47, 97688, Bad Kissingen, Deutschland

    J. Weiß

  2. Frauenklinik, Universitätsklinikum Erlangen, Universitätsstraße 21–23, 91054, Erlangen, Deutschland

    M.W. Beckmann

Authors
  1. J. Weiß
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.W. Beckmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to J. Weiß or M.W. Beckmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiß, J., Beckmann, M. Zur Therapie des Zervixkarzinoms. Gynäkologe 40, 903–907 (2007). https://doi.org/10.1007/s00129-007-2070-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-007-2070-z

Search

Navigation